# A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients

> **NCT01688531** · PHASE1 · COMPLETED · sponsor: **Galderma R&D** · enrollment: 38 (actual)

## Conditions studied

- Acne

## Interventions

- **DRUG:** CD0271 0.1%/CD1579 2.5% gel
- **DRUG:** CD0271 0.1%/CD1579 2.5% gel vehicle

## Key facts

- **NCT ID:** NCT01688531
- **Lead sponsor:** Galderma R&D
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-08
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2019-09-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01688531

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01688531, "A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01688531. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*